1. Home
  2. ESPR vs VEL Comparison

ESPR vs VEL Comparison

Compare ESPR & VEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$2.64

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

Logo Velocity Financial Inc.

VEL

Velocity Financial Inc.

HOLD

Current Price

$17.76

Market Cap

677.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
VEL
Founded
2008
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
731.9M
677.2M
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
ESPR
VEL
Price
$2.64
$17.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$7.60
$22.00
AVG Volume (30 Days)
5.0M
108.8K
Earning Date
03-10-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
60.71
43.98
EPS
N/A
2.75
Revenue
$403,135,000.00
N/A
Revenue This Year
$2.92
$6.01
Revenue Next Year
N/A
$19.02
P/E Ratio
N/A
$6.48
Revenue Growth
21.31
N/A
52 Week Low
$0.73
$16.12
52 Week High
$4.18
$21.40

Technical Indicators

Market Signals
Indicator
ESPR
VEL
Relative Strength Index (RSI) 42.52 48.65
Support Level $2.37 $17.74
Resistance Level $3.02 $18.23
Average True Range (ATR) 0.18 0.61
MACD 0.04 0.09
Stochastic Oscillator 54.44 41.41

Price Performance

Historical Comparison
ESPR
VEL

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

About VEL Velocity Financial Inc.

Velocity Financial Inc is a United States-based real estate finance company. Company operates in a large fragmented market with substantial demand for financing and limited supply of institutional financing alternative The company originates and manages investor loans secured by residential rental and small commercial properties. The company earns revenue in the form of interest income. It operates in New York, California, Florida, New Jersey, and other states.

Share on Social Networks: